Answers are grounded in this paper and cite their sources.
Inactivation of Mstn protects against the development of insulin resistance, proatherogenic dyslipidemia, and aortic atherogenesis in Ldlr(-/-) mice. Myostatin may be a useful target for drug development for prevention and treatment of obesity and its associated type 2 diabetes and atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: